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ABSTRACT
Introduction: The aim of this study was to
evaluate the effect of visually non-significant
cataract extraction in patients with hypotony
maculopathy and reduced visual acuity due to
over-filtering blebs after trabeculectomy.
Methods: Patients with intraocular pressure
(IOP)\6 mmHg and documented hypotony
maculopathy due to over-filtering blebs after
trabeculectomy were prospectively recruited.
Eligible patients underwent visually non-sig-
nificant cataract phacoemulsification, no earlier
than 12 weeks from the diagnosis of hypotony
maculopathy. IOP and visual acuity before and
after phacoemulsification were compared at 1
and 3 months from surgery. Correlations
between age, time interval between surgeries,
baseline IOP, bleb type and IOP and visual
acuity changes at 3 months after phacoemulsi-
fication were investigated.
Results: From January 2010 to September 2014,
20 consecutive adult patients met the inclusion
criteria. Before phacoemulsification, mean IOP
was 3.1 ± 1.6 mmHg. Following phacoemulsifi-
cation, mean IOP increased to 8.6 ± 4.1 mmHg
at 1 month (p\0.01) and to 9.1 ± 4.3 mmHg at
3 months (p\0.01). IOP elevation following
phacoemulsification was observed in 16 of 20
eyes (80%). Mean visual acuity improved from
Snellen 0.5 ± 0.1 to 0.6 ± 0.1 at 1 month
(p\0.01) to 0.7 ± 0.2 at 3 months (p\0.01)
after phacoemulsification. In 4 eyes in which
the IOP was not elevated, surgical revision of
the previous trabeculectomy was performed. No
significant correlations between investigated
variables, visual acuity and IOP changes at
3 months after phacoemulsification were
found.
Conclusion: Phacoemulsification of visually
non-significant cataract appears to be a safe and
effective technique for managing chronic ocular
hypotony with deep anterior chamber due to
over-filtering blebs.
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INTRODUCTION
The perioperative use of antimetabolites has
been shown to enhance the long-term efficacy
of trabeculectomy (TRB) and also increase the
incidence of postoperative complications
[1–3]. In eyes with very low intraocular pres-
sure (IOP) due to over-filtration or bleb leak-
age, sight-threatening complications can occur
[3, 4].
Over-filtration after TRB is not uncommon,
and is characterized by diffusely enlarged blebs,
ocular discomfort and, in more severe cases,
reduction in visual acuity due to hypotony
maculopathy. Different therapeutic approaches
have been attempted for this condition,
including bleb cryotherapy [5], autologous
blood injection [4, 6], re-suturing of the scleral
flap [7, 8] and conjunctival compression sutures
[9]. The majority of these interventions aims to
induce a fibro-vascular reaction at the level of
the bleb, thus increasing conjunctival resistance
to aqueous outflow and consequently reducing
over-filtration.
Cataract surgery has been shown to adversely
affect well-functioning TRB blebs [10–12].
Indeed, it has been shown that cataract surgery
increases the risk of TRB failure, and this risk is
higher if the time between TRB and cataract
surgery is relatively short [13]. The mechanism
implicated in TRB failure following cataract
surgery is thought to involve anterior chamber
inflammation that promotes fibrovascular pro-
liferation and subconjunctival healing
[10, 14–16]. Alterations in the consistency of
the aqueous humor after intraocular surgery
seem to play a role [17], since upregulation of
fibrogenic cytokines in the aqueous humor has
been documented [18].
As cataract surgery is an inflammation-in-
ducing procedure that promotes sub-conjunc-
tival healing in eyes with previous TRBs, it may
be beneficial in patients with over-filtering blebs
and hypotony. In the present study, we report
the effect of uncomplicated visually non-sig-
nificant cataract extraction in patients with
ocular hypotony due to an over-filtering TRB
bleb.
METHODS
In this prospective interventional case series,
patients with visually non-significant cataract
and over-filtering blebs causing hypotony, after
a TRB with intraoperative use of mitomycin C
(0.3 mg/ml for 3 min), were included. All pro-
cedures followed were in accordance with the
ethical standards of the responsible committee
on human experimentation (institutional and
national) and with the Helsinki Declaration of
1964, as revised in 2013. Informed consent was
obtained from all patients for being included in
the study. The trial was not registered on a
public repository because the data obtained for
the study were in accordance with our current
clinical practice.
All patients had their TRB performed at the
Glaucoma Service of the University of Brescia,
Brescia, Italy. Hypotony was defined as
IOP\6 mmHg,with reduced visual acuity due to
funduscopic and optical coherence tomography
(OCT) documented macular folds. Only patients
with deep anterior chamber and over-filtering
blebs showing no sign of resolution for at least
12 weeks after uncomplicated TRB were consid-
ered for phacoemulsification. Before considering
this approach, conservative measures were tried
in these patients, such as topical steroids suspen-
sion, sub-conjunctival peri-bleb injections of
autologous blood, topical aminoglycoside
administration (e.g., gentamycin). Patientswith a
follow-up of at least 3 months after the pha-
coemulsification were considered for analysis.
All TRBs and cataract surgeries were per-
formed by the same experienced surgeon (LQ).
TRBs were performed as proposed by Papado-
poulos and Khaw [19], while phacoemulsifica-
tion was performed under topical anesthesia
(lidocaine hydrochloride 4% eyedrops; Alfa
Intes srl, Casoria, Italy) through a 2.2;mm
temporal clear corneal incision. Foldable acrylic
intraocular lenses (AcrySof SN60AT; Alcon
Laboratories, Ft Worth, Tx, USA) were implan-
ted in the capsular bag. The post-operative
medical regimen included tobramycin eyedrops
(Tobral; Alcon Italia, Milan, Italy) four times
daily and flurometholone acetate eyedrops
(Flarex 0.1%; Alcon Italia) twice daily for
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10 days. The small dose of this relatively mild
steroid given for a short period of time was
decided on because it was deemed appropriate
to allow for a certain postoperative inflamma-
tion that would conceivably promote bleb
healing.
According to our current clinical practice,
patients undergoing phacoemulsification were
examined before surgery (baseline visit), at
1 week, and then at 1 and 3 months after sur-
gery. Additional visits were performed at the
discretion of the surgeon. Clinical examinations
at baseline and in all follow-up visits included
determination of best-corrected visual acuity
(BCVA), Goldmann applanation tonometry,
bleb evaluation at the slit lamp, fundoscopy and
OCT examination. At baseline, lens opacity was
graded using the Lens Opacities Classification
System III (LOCS III) [20]. Only eyes classified as
having no cataract or non-visually significant
cataract (LOCS III score B N01/NC1, C1 and P1)
were included in the study. To avoid any effect
of cataract on BCVA, LOCS III score at baseline
visit was compared with the score obtained
from patients’ charts before TRB, and only eyes
with matching data were included. Filtering
blebs were clinically categorized at the slit lamp
according with their extension on the scleral
surface. Type I were defined blebs with an
extension[270, whereas Type II were defined
blebs with an extension\270.
Surgical success was defined as IOP C 6 mm
Hg at the 3-month follow-up visit, without
additional medication. If IOP did not increase
3 months after phacoemulsification, surgical
revision of TRB site was performed. In this case,
the conjunctiva was reopened at the site of the
previous trabeculectomy and tight 10.0 nylon
sutures were applied to the scleral flap, in a
manner that no flow of aqueous humor from
the flap was detectable.
A non-parametric Wilcoxon test was used to
compare continuous variables, due to the rela-
tive small sample size and the skewed distribu-
tion of data. Spearman’s correlation coefficient
was used to evaluate the correlation between
continuous variables. The statistical significance
was set at 0.05 for a bilateral test. Analyses were
carried out using the SAS Software, v.9.2 (SAS
Institute, Cary, NC, USA).
RESULTS
From January 2010 to September 2014, 20
consecutive adult patients met the inclusion
criteria and were included in the study. Table 1
shows the demographics and clinical charac-
teristics of the patients. On average
(mean ± SD), phacoemulsification was per-
formed 23.9 ± 7.1 weeks after TRB. No compli-
cations occurred during or immediately after
surgery.
At baseline, mean IOP was 3.1 ± 1.6 mm Hg.
Following phacoemulsification, the mean IOP
increased to 8.6 ± 4.1 after 1 month (p\0.01)
and to 9.1 ± 4.3 mmHg after 3 months
(p\0.01) (Table 2). IOP elevation was observed
in the first post-operative month, and was sus-
tained until the 3-month follow-up visit (1-
month vs. 3-month IOP, p = 0.15). Surgical
success was achieved in 16 of 20 patients (80%).
Mean visual acuity improved from Snellen
0.5 ± 0.1 (range 0.2–0.7) at baseline to 0.6 ± 0.1
(range 0.2–0.9, p\0.01) at 1 month and to
0.7 ± 0.2 at 3 months (range 0.3–1.0, p\0.01)
after phacoemulsification (Table 2). In all cases
Table 1 Characteristics of the patients included in the
study
Characteristic Overall
Number of patients/eyes 20/20
Age, years





Lens opacity grading (LOCS III score), mean (SD)
Nuclear color/opalescence (N/NC) 0.64 (0.29)
Cortical (C) 0.72 (0.33)
Posterior subcapsular (P) 0.27 (0.33)
Timing of phacoemulsification, weeks
Mean (SD) 23.9 (7.1)
Min–max 14-36
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except one in which surgical success was
achieved, visual acuity improved and macular
folds either became less prominent or disap-
peared at OCT examination (Fig. 1).
At baseline, Type I and Type II blebs were
observed in 15 (75%) and 5 (25%) eyes, respec-
tively. At 3-month follow-up visit, Type I and
Type II blebs were observed in 9 (45%) and 11
(55%) eyes, respectively. This difference in bleb
morphology before and after phacoemulsifica-
tion was statistically significant (p\0.01). IOP
and visual acuity changes at 3 months after
cataract surgery did not correlate with patient
age (p = 0.29 and p = 0.94), time interval
between filtering surgery and phacoemulsifica-
tion (p = 0.34 and p = 0.4), baseline IOP (p = 0.7
and p = 0.73) and bleb type (p = 0.73 and
p = 0.66).
In four eyes (20%), the IOP did not increase
when compared with the value before
phacoemulsification. In these cases, surgical
revision of the scleral flap was performed. IOP
and visual acuity of these four eyes 1 month
after surgery are shown in Table 3. In two eyes
(50%), medical therapy was needed because of
inadequate IOP control.
DISCUSSION
The introduction of antimetabolites as an
adjunct to TRB has increased the success of the
procedure, but also the risk of vision-threaten-
ing complications, such as long-lasting hypot-
ony [4, 21–28]. Cataract is common in eyes that
have undergone TRB. Indeed, the Advanced
Glaucoma Intervention Study has shown that
TRB may increase the risk of cataract formation
by 78% [29]. However, the patients included in
our study did not have clinically significant lens
Table 2 Intraocular pressure and visual acuity before and after surgery





Mean (SD) 3.1 (1.6) 8.6 (4.1) 9.1 (4.3) 5.5 (3.8–7.2) 6.0 (4.2–7.7)
Min–max 0–6 2–17 2–16 p\0.01 p\0.01
BCVA, Snellen
Mean (SD) 0.5 (0.1) 0.6 (0.1) 0.7 (0.2) 0.1 (0.05–0.2) 0.2 (0.1–0.3)
Min–max 0.2–0.7 0.2–0.9 0.3–1.0 p\0.01 p\0.01
IOP intraocular pressure, BCVA best corrected visual acuity expressed in Snellen’s decimal fraction
Fig. 1 Intraocular pressure and best corrected visual acuity change at 3-month follow-up for each studied patient;
a intraocular pressure modification; b best corrected visual acuity modification
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opacity, at least when examined ophtalmo-
scopically. Consequently, in our patients with
chronic hypotony maculopathy, the reduced
preoperative visual acuity can reasonably be
assumed to be due to their macular condition,
rather than due to cataract. Thus, we believe
that the improvement in visual acuity after
phacoemulsification represents the effect of IOP
elevation on macular structure and function,
rather than the effect of cataract lens extraction.
Excessive scarring at the conjunctival–scleral
interface or within the scleral flap bed is the
main reason for TRB failure [6]. There are several
factors associated with excessive conjunctival
healing and scarring, such as race [30], previous
use of topical medication [31], and age [32]. The
increased bioavailability of inflammatory
mediators after cataract surgery can also
increase the risk of TRB bleb failure. Using laser
flare photometry, Chee et al. found that ante-
rior chamber flare is increased after pha-
coemulsification, while approximately 30 days
are needed before flare levels return to normal
[33]. Using the same technique, Siriwardena
et al. compared anterior chamber flare in 131
patients who underwent TRB and in 148
patients who underwent phacoemulsification
[34]. The authors found significantly higher
levels of anterior chamber flare in the pha-
coemulsification group at all postoperative time
points up to 3 months. Anterior chamber flare
in the phacoemulsification group returned to
preoperative levels by month 6. In contrast, in
the TRB group, flare levels returned to normal
after 4 weeks. The authors assumed that the
prolonged low-grade inflammation associated
with phacoemulsification is likely due to lens
crystallines, the effect of ultrasound energy, and
the high volume of fluid circulating through
the eye during surgery. More recently, Husain
et al. demonstrated in a randomized clinical
trial that cataract surgery after TRB increases the
risk of TRB failure, and that this risk is higher if
the time between TRB and cataract surgery is
shorter [13]. Conceivably, the elevated concen-
tration of inflammatory mediators in the aque-
ous humor following phacoemulsification
represents a risk factor for bleb failure.
In our series, phacoemulsification with
reduced topical steroid therapy in the post-op-
erative period increased the IOP in a significant
percentage of eyes (80%) with chronic hypot-
ony due to an over-filtrating TRB. Moreover,
bleb extension at 3 months after phacoemulsi-
fication showed a significant reduction in six
eyes. Our results are in accordance with those
reported by Doyle et al. in a smaller sample of
patients (nine eyes) [35]. A potentially relevant
difference between our technique and that of
Doyle et al. is that these authors were leaving
viscoelastic in the anterior chamber at the end
of the procedure [35]. It is unclear if the passage
of viscoelastic material in the subconjunctival
space could further enlarge the filtration area.
In addition, it could be argued that viscoelastic
material remaining under the bleb could
potentially reduce the healing effect promoted
by phacoemulsification-induced inflammation.
Moreover, in the series of Doyle et al. [35], one
patient had a transient but large IOP spike. In
our series, no IOP spikes were recorded in any
patient.
Patients included in this study had pro-
longed over-filtering conjunctival blebs associ-
ated with hypotony, and did not respond to
conservative measures. Therefore, we believe
that spontaneous resolution of hypotony would
be unlikely in these patients, and that our
results are explained by our intervention, rather
than the natural course of the condition. Four
patients in our series did not show any IOP
Table 3 Intraocular pressure and best corrected visual
acuity in patients undergone surgical revision of
trabeculectomy










#1 2 16 0.2 0.4
#2 4 18 0.7 0.8
#3 2 19a 0.4 0.6
#4 2 20a 0.6 0.6
IOP intraocular pressure, BCVA best corrected visual
acuity expressed in Snellen’s decimal fraction
a Patients needed topical hypotensive therapy
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increase after phacoemulsification. In these
patients, surgical revision of the scleral flap was
performed. However, two eyes (50%) developed
high IOP, and topical hypotensive medical
therapy was needed to control IOP. These data
are in accordance with the literature [7], and
make flap revision a suboptimal way to manage
these patients.
Hypotony caused by excessive bleb filtration
often resolves with conservative postoperative
management [36]. In our clinical practice, if an
anterior chamber is present and there is no sign
of hypotony maculopathy, a wait-and-see
behavior is generally adopted, tapering topical
steroids until IOP spontaneously rises. However,
when hypotony maculopathy develops, prompt
intervention is needed. Conservative proce-
dures are the first step. Sub-conjunctival peri-
bleb injection of autologous blood, associated
with topical aminoglycoside administration
(e.g., gentamycin), is our first intervention. If
no rise in IOP is evidenced shortly, a more
invasive procedure is chosen. In patients with
over-filtrating blebs extending less than 270 on
the scleral surface, two or more 9.0 nylon
compression sutures are placed. In our hands,
this procedure resolved hypotony in 64.4% of
eyes in a series of patients affected with hypot-
ony maculopathy and over-filtration [9]. If bleb
extends over 360, or compression sutures are
not effective, surgical revision of the scleral flap
is suggested. This procedure is generally effec-
tive; however, IOP spikes after surgery are not
rare, and the risk of intra-operative complica-
tions is high [7]. In comparison with these
procedures, phacoemulsification of clear lens
has shown excellent results in this study,
resolving hypotony in 80% of patients at
3 months, with no intra- or extra-operative
complications.
Long-term results of interventions for over-
filtering blebs associated with hypotony macu-
lopathy is unknown. In a small case series of
eyes affected with hypotony maculopathy after
trabeculectomy by Schwartz et al., four eyes
underwent resuturing of the scleral flap to
reverse excessive filtration. The procedure
resulted in improved visual acuity in all cases,
with IOP between 6 and 17 mm Hg with no
topical medications (minimum follow-up:
18 months) [37]. Trans-conjunctival suturing of
the scleral flap has been proposed by Eha et al.
to treat eyes with hypotony maculopathy
attributable to over-filtration after trabeculec-
tomy with MMC. This procedure was performed
in 53 eyes with a mean baseline IOP of
3.55 mmHg (± 2.05; range 0–8 mmHg) and a
mean visual acuity of 0.8 LogMar. At 4-year
follow-up, IOP and visual acuity increased to
9.5 mmHg and 0.3 LogMar, respectively. Mac-
ular folds resolved in all patients [38]. Okada
et al. performed peri-bleb injections of autolo-
gous blood in five eyes with excess filtration and
hypotony after trabeculectomy, but without
hypotony maculopathy. After a mean
31-month follow-up, all eyes had well-con-
trolled IOP while visual acuity in three eyes was
much improved [39]. Due to small sample size
and no rigorous methodology, further research
is needed to establish the best surgical approach
for these patients and the long-term outcomes.
Hypotony can induce a shortening of the eye,
which may affect biometry. If the eye is restored
to its pre-TRB axial length, the IOL might not be
of the appropriate power. For this reason, it is
important to always assess ocular biometry
before TRB, in order to also implant the correct
IOL in these eyes affected with hypotony.
In our study, IOP and visual acuity changes
after 3-month follow-up were not correlated
with age, time interval between surgeries,
baseline IOP and bleb type. However, these
results should be interpreted with caution, due
to the small sample size of the study, the rela-
tively short follow-up and the absence of a
control group. Another limitation of our study
was the absence of an objective grading for
macular folds. However, OCT has demonstrated
to be extremely sensitive in detection of macu-
lar folds in patients affected with hypotony
maculopathy [40], and subjective comparison of
OCT scans may be an accurate approach to
follow-up this condition.
CONCLUSION
In conclusion, phacoemulsification of visually
non-significant cataract appears to be a safe and
effective technique for managing chronic ocular
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hypotony with deep anterior chamber due to
over-filtering TRB blebs.
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